Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia
Related Experiment Video
Updated: Jan 3, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Zhihua Wang1, Lei Yang2, Jing Ye1,3
1Tianjin Hospital of Integrated Traditional Chinese and Western Medicine, Tianjin Nankai Hospital, Tianjin, China.
Abstract:
The aim of this study was to evaluate the changes in the three subsets of monocyte (classical, intermediate, and non-classical) and the expression of human leukocyte antigen-DR (HLA-DR) on monocyte subsets during MP pneumonia in children. Monocyte subsets were analyzed in the peripheral blood of healthy volunteers and MP pneumonia patients at the stages of admission and remission after clinical therapy. They were defined as classical (CD14+CD16-), intermediate (CD14brightCD16+), and non-classical (CD14dimCD16+) using flow cytometry. Furthermore, three subsets of monocyte were analyzed for the expression of HLA-DR. Patients with MP pneumonia at admission had a higher proportion of intermediate and non-classical monocytes than healthy subjects (all P < 0.05). The proportion of intermediate subset and non-classical subset was lower in MP pneumonia patients at remission than at admission (all P < 0.05). In comparison with the other monocyte subsets, intermediate subset showed a significantly higher percentage of HLA-DR in MP pneumonia patients at admission (P < 0.05). Further analysis revealed that the expression of HLA-DR on intermediate subset was lower in severe patients than in non-severe patients (P < 0.05).Our data has shown for the first time that MP pneumonia is associated with the increased proportion of non-classical and intermediate monocytes, indicating the involvement of monocyte-related mechanisms in the pathogenesis of this disease. Additionally, the decreased expression of HLA-DR on CD14brightCD16+ subset may be a potential indicator of the severity of MP pneumonia.
Insights
Pediatric Mycoplasma pneumoniae (MP) pneumonia is linked to increased intermediate and non-classical monocytes. Lower human leukocyte antigen-DR (HLA-DR) expression on intermediate monocytes may indicate disease severity.
Area of Science:
- Immunology
- Pediatric Infectious Diseases
Background:
- Monocytes play a crucial role in immune responses.
- Mycoplasma pneumoniae (MP) pneumonia is a common respiratory infection in children.
- Understanding monocyte subset dynamics in MP pneumonia is essential for diagnosis and prognosis.
Purpose of the Study:
- To investigate changes in monocyte subsets (classical, intermediate, non-classical) and human leukocyte antigen-DR (HLA-DR) expression during pediatric MP pneumonia.
- To correlate these changes with disease severity and clinical outcomes.
Main Methods:
- Flow cytometry was used to analyze monocyte subsets (CD14+CD16-, CD14brightCD16+, CD14dimCD16+) in healthy children and MP pneumonia patients.
- HLA-DR expression on monocyte subsets was quantified at admission and remission stages.
- Patients were categorized into severe and non-severe groups.
Main Results:
- MP pneumonia patients exhibited higher proportions of intermediate and non-classical monocytes compared to healthy controls.
- Monocyte subset proportions decreased at remission compared to admission.
- The intermediate monocyte subset showed higher HLA-DR expression at admission.
- Lower HLA-DR expression on intermediate monocytes was observed in severe MP pneumonia cases.
Conclusions:
- Pediatric MP pneumonia is associated with an increased proportion of non-classical and intermediate monocytes, suggesting their involvement in the disease's pathogenesis.
- Decreased HLA-DR expression on intermediate monocytes (CD14brightCD16+) may serve as a potential biomarker for MP pneumonia severity in children.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013